Sorrento Therapeutic’s COVID-19 Test

Sorrento’s COVID-19 test appears to be superior to competing diagnostics, and it just made a good acquisition, while its overall strategy is sound.

Sorrento has produced a coronavirus test which is expected to be approved and then become widely used in the U.S. and potentially around the world.  The company requested emergency use authorization (EUA) from the Food and Drug Administration for its COVI-TRACK diagnostic test, which detects novel coronavirus antibodies. It also plans to file for an EUA for COVI-TRACE, a rapid salivary diagnostic test licensed from Columbia University.

Sorrento has been even more active in developing potential treatments for COVID-19. The biotech filed for FDA approval earlier this month to begin a phase 1 study of antibody therapy STI-1499 (COVI-GUARD) in treating hospitalized COVID-19 patients. It hopes to quickly advance the candidate through clinical testing and perhaps even receive an EUA for STI-1499 as soon as the end of 2020.

a number of test tubes and capsules are pictured under a cool blue light

Source: Shutterstock

Sorrento’s coronavirus test yields results in just 30 minutes, does not require lab equipment and doesn’t have to be sent to labs. As a result, it, unlike other tests, could be used by hospitals, stadiums, hotels, office buildings and other organizations to allow people to safely enter their facilities on the same day that the test is taken.


References:

  1. https://investorplace.com/2020/08/sorrentos-covid-19-test-acquisitions-should-help-srne-stock-surge/
  2. https://www.fool.com/investing/2020/08/24/why-sorrento-therapeutics-stock-is-sinking-today/

U.S. FDA Approves COVID-19 Plasma Treatment for Emergency Use Authorization

Eradicating the coronavirus, whether it’s through an effective therapeutic treatment or vaccine, is the key to unlocking the economy.

The U.S. Food and Drug Administration’s granted emergency use authorization of antibody-rich plasma from recovered patients which may lessen the severity of the disease, but experts suggest further research is needed.

Convalescent plasma therapy is an experimental treatment that some physicians are using for people with severe coronavirus disease 2019 (COVID-19). The plasma therapy has shown some promise in battling severe illness. People who’ve recovered from COVID-19 have antibodies — proteins the body uses to fight off infections — to the disease in their blood. The blood from people who’ve recovered is called convalescent plasma.

Researchers hope that convalescent plasma can be given to people with severe COVID-19 to boost their ability to fight the virus. It also might help keep people who are moderately ill from becoming more ill and experiencing COVID-19 complications, according to the Mayo Clinic.

Alex Azar, the U.S. health and human services secretary, said during a White House press briefing on Sunday that the treatment has been delivered to more than 70,000 American patients so far. The treatment, according to the FDA’s evaluation, “may be effective in lessening the severity or shortening the length of COVID-19 illness in some hospitalized patients.”

Source: The New York Times Coronavirus Vaccine Tracker

Over 400 vaccines and therapietic treatments are under study as researchers rush to produce effective medicines for the disease. And, 32 of the vaccines are in human trials. The FDA says that for any vaccine to be approved, it will need to prevent infection or decrease its severity in at least 50% of the people vaccinated. The goal is to inoculate enough people with a vaccine that immunity spreads through a community, even if not everyone gets the vaccine. It’s called “herd immunity”, according to WebMD.

For this coronavirus, some experts say about 60% to 70% of the population would need to develop antibodies, whether from a vaccine or getting and recovering from COVID-19, to create herd immunity.

Currently, the most effective ways to protect yourself and others from being infected by the virus are to:

  • Clean your hands frequently and thoroughly
  • Avoid touching your eyes, mouth, and nose
  • Cover your cough with the bend of elbow or tissue
  • Stay home and isolate yourself if you feel ill or ‘under-the-weather’
  • Maintain social physical distance of at least 6 feet from others

Wearing a mask or face covering is no substitute for these additional effective measures.


References:

  1. https://www.mayoclinic.org/tests-procedures/convalescent-plasma-therapy/about/pac-20486440
  2. https://www.cnet.com/news/coronavirus-plasma-treatment-approved-for-emergency-use-but-questions-remain/
  3. https://www.webmd.com/lung/news/20200610/covid-19-latest-updates

Cotton cloth masks are effective preventing spread of virus

“Cloth face coverings are one of the most powerful weapons we have to slow and stop the spread of the virus – particularly when used universally within a community setting.”  Robert R. Redfield, director of the Centers for Disease Control and Prevention

A group of researchers from Duke University are providing answers to the continuing questions about the efficacy of masks.  The researchers analyzed forteen different facial coverings ranging from hospital-grade N95 respirators to bandanas. Of the 14 masks and other coverings tested, the study found that some easily accessible cotton cloth masks are about as effective as standard surgical masks, while popular alternatives such as neck gaiters made of thin, stretchy material may be worse than not wearing a mask at all.

A fitted N95 mask proved was the most effective from the tests noting that the mask allowed “no droplets at all” to come out, according to researchers. Meanwhile, a breathable neck gaiter ranked worse than the no-mask control group.

Neck gaiters are extremely convenient since which they don’t restrict air and droplets which is the reason why they’re not doing much of a job helping people stopping the spread of the virus.

Several studies find that wearing masks will curb the transmission and reduce the risk of coronavirus infection.  Masks do work and they do cut down transmission of the virus.  And, some masks are better than others.


References:

  1. https://www.washingtonpost.com/lifestyle/wellness/mask-test-duke-covid/2020/08/10/4f2bb888-db18-11ea-b205-ff838e15a9a6_story.html?utm_source=twitter&utm_medium=social&utm_campaign=wp_main
  2. https://www.washingtonpost.com/health/2020/06/13/spate-new-research-supports-wearing-masks-control-coronavirus-spread/

55% of coronavirus patients still have neurological problems three months later | MarketWatch

Published: Aug. 9, 2020 at 9:11 a.m. ET By Nicole Lyn Pesce

Mounting evidence suggests COVID-19 could cause brain damage in adults and kids

“While lung scarring, heart and kidney damage may result from COVID-19, doctors and researchers are starting to clock the potential long-term impact of the virus on the brain.”

“Many COVID-19 patients have continued showing symptoms for months after the initial infection passed, reported neurological problems such as confusion and had difficulty concentrating (or brain fog), as well as headaches, extreme fatigue, mood changes, insomnia and loss of taste and/or smell.”

“The CDC recently warned that it takes longer to recover from COVID-19 than the 10- to 14-day quarantine window that has been touted throughout the pandemic. In fact, one in five young adults under 34 was not back to their usual health up to three weeks after testing positive. And 35% of surveyed U.S. adults overall had not returned to their normal state of health when interviewed two to three weeks after testing.”

“Now a study of 60 COVID-19 patients published in Lancet this week finds that 55% of them were still displaying such neurological symptoms during follow-up visits three months later. And when doctors compared brain scans of these 60 COVID patients with those of a control group who had not been infected, they found that the brains of the COVID patients showed structural changes that correlated with memory loss and smell loss.”

“The most severe illness and complications of COVID-19 appear to stem from the body’s immune response to the viral invader, as opposed to the virus itself causing damage.”

Read more: https://www.marketwatch.com/story/55-of-coronavirus-patients-still-have-neurological-problems-three-months-later-study-2020-08-07?mod=mw_latestnews&link=sfmw_fb

How Vaccines Work, How They’re Developed and What’s the Latest on One for COVID-19

By Andrea Klemes, DO, FACE, CMO MDVIP

Since the coronavirus pandemic began in early 2020, we’ve heard a lot about vaccines. There have been promises for quick vaccine development as well as warnings about how long it really takes to develop a safe, effective vaccine.

You’ve also probably heard that a coronavirus vaccine is necessary for us to return to normal. The good news? Surprising progress has been made in creating vaccines for COVID-19. As of now, there are more than 160 vaccines in various stages of development, and many are already into the human testing phase. While the path to success is still uncertain, never in human history have so many scientists and resources been devoted to a single public health crisis.

In July, multiple vaccine manufacturers released preliminary data from phase 1 studies that showed new vaccines are well tolerated and created antibodies. This is good news because it shows success in human subjects; in phase 1 trials, small groups of people receive the vaccine. Three vaccines are either currently in a later phase of development, where they are being tested on thousands of people, or about to enter that phase.

While it’s good news, there’s a long way to go. Here’s a quick primer on how vaccines work, how they’re developed and where we stand developing a vaccine for the current coronavirus outbreak.

How Vaccines Work
Vaccines work by mimicking a virus or bacteria that enters the immune system to build up antibodies. Ironically, vaccines are one of our oldest modern medical treatments. The first effective vaccination — to smallpox — was developed in the late 18th century. Over the last 220 years, scientists have advanced the process and effectiveness for vaccines.

Modern vaccines are simple in concept: create a synthetic compound that behaves like a real live pathogen that doesn’t cause illness. The compound will instead provoke the immune system to create antibodies that teach the body to react quickly and forcefully if the real pathogen invades the body.

Antibodies are an essential part of your immune system. When a pathogen, like bacteria or a virus, invades your body, antibodies bind to the invader and neutralize it, minimizing its damage. Your body came with some antibodies, which were passed from your mother. But most antibodies are developed over time when you’re exposed to pathogens. Vaccines make that natural process happen without infecting you with a real virus or bacteria.

How Vaccines Are Made
There are four basic types of vaccines, but regardless of the type, the process to produce safe and effective vaccines is typically long and difficult. When we’re not in crisis mode, vaccine labs can take anywhere from 10 to 15 years to develop a new vaccine. Of course, when we’re in the throes of a pandemic, labs generally move quicker. For example, during the mumps outbreak, a vaccine was generated in four years – the quickest in U.S. history.

Labs are currently working on an even faster timetable, with hopes that a COVID-19 vaccine might be available by the end of 2020 or by the middle of next year.

The reason it takes so long it that there are five phases of vaccine development:

  • Exploration: In this stage, drug companies investigate different approaches to the vaccine. Historically, this phase lasts between two and four years; however, evolving technology has help quicken the pace of this phase for some vaccines, including COVID-19. Another factor that has helped speed up the exploratory stage of the COVID-19 vaccine is information sharing among scientists; for example, scientists genetically mapped the virus as early as January — something that would have taken much longer 10 or 20 years ago. Also, since COVID-19 is similar to SARS — another coronavirus that caused a six-month pandemic in 2003 — scientists working on the COVID-19 vaccine were able to learn from those working on the SARS vaccine — a significant head start.
  • Preclinical: Once researchers develop a vaccine candidate, it’s tested in cell cultures and animals to see if it triggers an immune response without damaging cells. This takes about a year. And if the vaccine doesn’t work, researchers circle back to the exploration phase. But if it is successful, it moves on the testing phase.
  • Testing: Vaccines are tested through clinical trials – research studies that evaluate the effectiveness and safety of vaccines, medications, medical devices, surgical procedures or behavioral interventions on a group of people. Most trials start with a small group of people (phase 1), and, if they go well, they are expanded to include a moderate size group of people (phase 2) and then a large group (phase 3). Of course, if issues arise during clinical trials, the vaccine reverts to the preclinical phase.
  • Regulatory review: If clinical trials go well, the drug company submits a Biologics License Application and product label for the vaccine. In the United States, applications and labels are sent to the U.S. Food and Drug Administration (FDA). In the U.S., this process takes about 10 months, although in a circumstance such as the COVID-19 pandemic, the process will probably be accelerated.
  • Production: Once the drug manufacturers have been given a green light, they can begin producing the vaccine. In the U.S., the FDA continues overseeing the production of the vaccine.


Where COVID-19 Vaccines Stand

At the end of July there were 23 vaccines in clinical testing and another 137 in pre-clinical development, according to the World Health Organization.

Dr. Erica Saphire, an infectious disease authority and professor at La Jolla Institute for Immunology, recently told medical officials that the earliest a vaccine may be available is January 2021, but it’s more likely that a viable vaccine won’t be available until July 2021 or later. Even when one is available, it will take time to get the vaccine manufactured and distributed. Of course, once a vaccine is available, healthcare workers, first responders and those at the highest risk – nursing home patients, for example — will probably be the first to have access to the vaccine.

Until a vaccine is available, continue to take precautions such as wearing a face mask and social distancing to lower your risk of contracting COVID-19. And continue working closely with your physician to help you control chronic conditions and maintain a strong immune system that can lower your chances of developing serious complications should you catch COVID-19.

Military service academies plan for students’ return in fall | Military Times

“We cannot develop leaders for our nation’s military online”. Vice Admiral Sean Buck, USN, Superintendent, U.S. Naval Academy, Class of 1982.

The U.S. Naval Academy is planning to have its 4,400 midshipmen return to campus in Annapolis, Maryland, for the fall, after students completed the last semester with online learning from their homes around the nation due to the coronavirus, academy officials said Monday.

Vice Adm. Sean Buck, the superintendent, told the academy’s Board of Visitors he has been communicating with the leaders of the nation’s other service academies, and they also plan to have their students on campus in the fall.

“I can tell you, as of this morning, every single military service academy in this country is opening in the fall,” Buck told the board in an online meeting. “We all are developing very detailed plans with regards to health, safety and the protocols that we need to put in place to manage risk.”

While academics can be done online, Buck said the other two pillars of the academy’s mission statement are developing midshipmen morally and physically, and those goals require hands-on experiences on campus.

Read more: https://www.militarytimes.com/news/your-military/2020/06/01/military-service-academies-plan-for-students-return-in-fall/?utm_source=facebook.com&utm_campaign=Socialflow+MIL&utm_medium=social

Miscalculating Risk: Confusing Scary With Dangerous | Brian Wesbury, First Trust Economics Blog

“Coronavirus…is the first social media pandemic.”

The coronavirus kills, everyone knows it. But this isn’t the first deadly virus the world has seen, so what happened? Why did we react the way we did? One answer is that this is the first social media pandemic. News and narratives travel in real-time right into our hands.

Brian Wesbury, Chief Economist

This spreads fear in a way we have never experienced. Drastic and historically unprecedented lockdowns of the economy happened and seemed to be accepted with little question.

We think the world is confusing “scary” with “dangerous.” They are not the same thing. It seems many have accepted as fact that coronavirus is one of the scariest things the human race has ever dealt with. But is it the most dangerous? Or even close?

There are four ways to categorize any given reality. It can be scary but not dangerous, scary and dangerous, dangerous but not scary, or not dangerous and not scary.

Clearly, COVID-19 ranks high on the scary scale. A Google news search on the virus brings up over 1.5 billion news results. To date, the virus has tragically killed nearly 100,000 people in the United States, and more lives will be lost. But on a scale of harmless to extremely dangerous, it would still fall into the category of slightly to mildly dangerous for most people, excluding the elderly and those with preexisting medical conditions.

In comparison, many have no idea that heart disease is the leading cause of death in the United States, killing around 650,000 people every year, 54,000 per month, or approximately 200,000 people between February and mid-May of this year. This qualifies as extremely dangerous. But most people are not very frightened of it. A Google news search for heart disease brings up around 100 million results, under one-fifteenth the results of the COVID-19 search.

Read more: https://www.ftportfolios.com//blogs/EconBlog/2020/5/26/miscalculating-risk-confusing-scary-with-dangerous


Brian Wesbury is Chief Economist at First Trust Advisors L.P.

Hydroxychloroquine not approved to treat COVID-19

Pushing a malaria drug

The Trump Administration has touted hydroxychloroquine to treat patients with COVID-19, despite a paucity of scientific evidence that it’s an effective treatment. The drug, hydroxychloroquine, is a popular malaria and lupus treatment.

The Trump administration continues to cite small unscientific studies in China and France as evidence that hydroxychloroquine helps treat COVID-19 patients. The most recent study came from China and found that the anti-malaria drug helped speed the recovery of a small number of patients who were mildly or moderately ill, though notes that the evidence is limited.

The report anecdotal findings from China and France revealed that virus symptoms of cough, fever and pneumonia went away faster and that patients’ illness were less likely to become severe after administering hydroxychloroquine.

The FDA has not approved hydroxychloroquine to treat COVID-19, though it has granted it limited emergency-use authorization. But medical experts warn that reports of the drug’s benefits for COVID-19 patients are anecdotal and small-scale. And, there is little scientific evidence that proves it efficacy against the coronavirus.

Medical experts warn of hydroxychloroquine potentially severe side effects, which can include impaired vision, hearing loss, paranoia and cardiac arrhythmias, which could be fatal for patients with heart problems or who are taking certain antidepressants. “It is not like water. It is not harmless,” one emergency-room doctor and research scientist said.

The administration’s touting of chloroquine has already created a shortage, making it unavailable for some patients with existing prescriptions for the drug.

Dr. Anthony Fauci, the director of the National Institute of Allergy and Infectious Diseases, has repeatedly said it’s too soon to say if the drug would be effective against COVID-19.


References:

  1. https://www.marketwatch.com/story/trump-again-touts-unproven-drug-to-treat-coronavirus-what-do-you-have-to-lose-2020-04-05?link=sfmw_fb
  2. https://www.usatoday.com/story/news/health/2020/04/06/hydroxychloroquine-trump-anthony-fauci-peter-navarro-whos-right/2953317001/

Asymptomatic People Should Wear Face Masks

Updated: April 4, 2:53 p.m.

CDC: Use Face Coverings in Public

As more studies show that people without symptoms of COVID-19 are spreading the virus, the CDC is advising that people use cloth masks or face coverings in public.

Scientists now know that a portion of people  with the coronavirus may lack symptoms – possibly 25% or higher. And others who are pre-symptomatic can transmit the virus before they show signs of COVID-19.

“In light of this new evidence, the CDC recommends wearing cloth face coverings,” U.S. Surgeon General Jerome Adams, MD, said, including in grocery stores and pharmacies. “The CDC is always looking at the data and evolving the recommendations, and new ones will come as the evidence dictates.”

The guideline discourages people from using medical-grade or surgical-grade masks, such as N95 masks, and instead, leave those for medical professionals. People can purchase basic cloth or fabric masks online or make them at home.

If people choose to wear a face covering, they should wash their hands first, Adams said. They should not touch their faces while wearing a mask, and carefully remove the mask after use and wash their hands.

“This is all about you protecting me and me protecting you,” Adams said.

The new precaution doesn’t replace CDC guidance on social distancing, including staying at home as much as possible. That includes staying six feet away from others, not shaking hands, and washing hands with soap and water for 20 seconds throughout the day.

Asymptomatic spread of COVID-19

“It’s good to think about wearing a mask as protecting your community and asking your community to do the same for you.” Jeremy Howard

However, the idea of universal face mask use in the U.S. has been gaining support with the growing belief by health experts that many people who have no idea they are infected are spreading the virus because they either have no symptoms or have not begun to experience symptoms.

A study by researchers in Singapore estimated that around 10% of new coronavirus infections may be spread by people who carry the virus but have not displayed any symptoms such as fever, cough, difficulty breathing or sore throat.

And, according to Jeremy Howard, a Melbourne-raised research scientist at the University of San Francisco who has become one of America’s leading champion of universal mask-wearing, stated that, “The primary transmission [of coronavirus] is now known to be droplet-based, and we now know that that transmission largely occurs in the first seven days after infection, when people are largely asymptomatic. So that means that if you’re highly infectious, you probably won’t know it. So we should all assume that we are potentially lethal to people around us. The way we are potentially lethal to people around us is when we speak: that’s when these micro droplets get ejected up to six feet.”

In response, the CDC has changed how it defined the risks of infection, saying essentially that anyone may be a carrier, whether they have COVID-19 symptoms or not. But neither it nor the World Health Organization changed their recommendations that everyone did not have to wear masks.

CDC reconsiders guidance to wear masks 

There is a growing number of Americans and vocal proponents of wearing face masks believe that wearing a mask reduces how many times they touch their eyes, nose and mouth, “but there aren’t any data to support that that’s a useful intervention,” Dr. Schaffner says.

There has been a fair amount of person-to-person coronavirus spread by people not showing symptoms, the CDC will look at whether having more Americans wear masks will prevent transmission of COVID-19.

Nevertheless, staying at home, “social distancing” and washing your hands remain the most important things people can do to help flatten the curve and mitigate the spread of the coronavirus.


References:

  1. https://time.com/5794729/coronavirus-face-masks/
  2. https://www.foxbusiness.com/technology/coronavirus-carrier-covid-asymptomatic-pandemic
  3. https://www.theguardian.com/world/2020/apr/02/face-masks-coronavirus-covid-19-public
  4. https://www.bbc.com/news/world-us-canada-52148534
  5. https://www.bbc.com/news/science-environment-52126735
  6. https://thehill.com/changing-america/well-being/prevention-cures/490579-surgeon-general-asks-cdc-to-review-guidance-on

Should You Wear a Mask | Mayo Clinic

Should you wear a face mask to protect yourself from the virus, even if you’re not sick?

In a video posted by Dr. Nipunie Rajapakse, a Mayo Clinic infectious diseases specialist, states CDC current recommendation:

“The current recommendations regarding masks are that if you yourself are sick with fever and cough, you can wear a surgical mask to prevent transmission to other people. If you are healthy, there is not thought to be any additional benefit to wearing a mask yourself because the mask is not airtight and does not necessarily prevent breathing in of these viral particles, which are very tiny,” says Dr. Nipunie Rajapakse, a Mayo Clinic infectious diseases specialist.

If you are going to a clinic or hospital to be seen by a health care provider because of concerns of cough or fever, Dr. Rajapakse recommends wearing a face mask to avoid transmitting possible infection or virus to other patients and medical staff. Face masks also are recommended for health care workers and people who are taking care of someone infected with COVID-19 in close settings (at home or in a health care facility).

“Most people who do not work in a health care setting have not received training on how to put on and take off the masks properly. Doing this incorrectly can actually increase your risk of infection. Also, people who are wearing masks tend to touch their face more than those who are not, which can paradoxically result in an increased risk of infection as well,” says Dr. Rajapakse.

She says instead of wearing masks, people need to:

  • Wash their hands frequently using soap and water for 20 seconds or an alcohol-based hand rub.
  • Avoid touching their eyes, nose and mouth.
  • Practice cough etiquette. Cough into a flexed elbow or tissue, discard the tissue in the trash, and wash hands.
  • Stay home from school, work and public places if feeling unwell.


  1. Nipunie Rajapakse, M.D./Infectious Diseases/Mayo Clinic
  2. https://newsnetwork.mayoclinic.org/discussion/covid-19-when-should-you-wear-a-face-mask/